RiverVest

Feb 16, 2010
Urology Study Shows Reduced Side Effects From Radiation For Prostate Cancer With Calypso Medical’s Tumor Tracking Technology
Jan 05, 2010
Excaliard Initiates Phase 2 Trials in U.S. For Its Skin Scarring Drug, EXC 001
Jan 05, 2010
CyDex Pharmaceuticals Receives a Key U.S. Patent for Composition of Matter and Process of Manufacturing High-Purity Captisol®
Dec 15, 2009
Accumetrics Closes 2009 with Positive Outlook

RiverVest Venture Partners® is a venture capital firm focused on identifying and shaping early-stage life science companies to create significant shareholder value. With hands-on, high-level expertise and financial resources, RiverVest supports entrepreneurs by helping them achieve near-term objectives that position their companies for exit.

Case Study:

VC Partner as Sounding Board

Salient Surgical Technologies, Inc., founded as TissueLink Medical, Inc. in 1999, has successfully achieved market acceptance and strong revenue growth. But it took steady leadership and some skillful maneuvering to manage the inevitable bumps along the way. Read more >

“To have a trusted advisor — someone I can count on no matter how difficult the conversation? That’s worth its weight in gold!” — Joe Army, CEO – Salient Surgical Technologies, Inc.